08/30/2024 8:00 PM | ADMA Biologics (Subject) Kestenberg-Messina Kaitlin M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 8:02 PM | ADMA Biologics (Issuer) Grossman Jerrold B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 8:05 PM | ADMA Biologics (Issuer) Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 8:26 PM | ADMA Biologics (Subject) Grossman Jerrold B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024 8:22 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/27/2024 8:00 PM | ADMA Biologics (Issuer) KWON YOUNG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 8:28 PM | ADMA Biologics (Subject) Grossman Adam S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/14/2024 8:05 AM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 4:00 PM | ADMA Biologics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024 8:00 PM | ADMA Biologics (Issuer) Tade Brad L. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/26/2024 8:05 PM | ADMA Biologics (Issuer) Tade Brad L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 8:10 PM | ADMA Biologics (Issuer) Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 4:15 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 8:01 PM | ADMA Biologics (Issuer) Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:34 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:15 PM | ADMA Biologics (Subject) Grossman Adam S (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 8:00 AM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 4:01 PM | ADMA Biologics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 3:06 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 3:35 PM | ADMA Biologics (Filer)
| Form DEFA14A | |
04/15/2024 3:40 PM | ADMA Biologics (Filer)
| Form ARS | |
04/15/2024 3:31 PM | ADMA Biologics (Filer)
| Form DEF 14A | |
04/02/2024 8:00 PM | ADMA Biologics (Issuer) Kestenberg-Messina Kaitlin M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/02/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 8:01 PM | ADMA Biologics (Issuer) Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 8:48 PM | ADMA Biologics (Issuer) ELMS STEVE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 8:00 PM | ADMA Biologics (Issuer) ELMS STEVE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:44 PM | ADMA Biologics (Subject) Aisling Capital II LP (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 11:31 AM | ADMA Biologics (Subject) TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G/A | |
03/11/2024 11:24 AM | ADMA Biologics (Subject) TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
03/11/2024 11:19 AM | ADMA Biologics (Subject) Nuveen Asset Management, LLC (Filed by)
| Form SC 13G/A | |
03/08/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 8:01 PM | ADMA Biologics (Issuer) LENZ BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 8:00 PM | ADMA Biologics (Issuer) LENZ BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) ELMS STEVE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) Fong Bryant (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) Guiheen Lawrence P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) KWON YOUNG (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Biden’s Capital Gains Tax to Devastate Savings! (Ad) Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9456&Placement=NativeDisplay&Source=NativeDisplay) >> Get Your FREE Wealth Protection Guide << |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Jerrold B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:00 PM | ADMA Biologics (Issuer) FINGER ALISON CECILY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:15 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 3:21 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 8:03 PM | ADMA Biologics (Issuer) LENZ BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:00 AM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 10:47 AM | ADMA Biologics (Subject) TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G | |
02/14/2024 10:50 AM | ADMA Biologics (Subject) Nuveen Asset Management, LLC (Filed by)
| Form SC 13G | |
02/14/2024 10:37 AM | ADMA Biologics (Subject) TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G | |
01/08/2024 7:00 AM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 6:30 AM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 8:00 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 8:00 PM | ADMA Biologics (Issuer) LENZ BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:30 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 3:30 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2023 3:31 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2023 8:00 PM | ADMA Biologics (Issuer) LENZ BRIAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 8:02 PM | ADMA Biologics (Issuer) Grossman Adam S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:45 PM | ADMA Biologics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 3:46 PM | ADMA Biologics (Issuer) FINGER ALISON CECILY (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |